Skip to main contentSkip to navigation
Sirius Investors
Health Sciences Group, Inc.

Health Sciences Group, Inc.

HESG
OTCHealthcare

Health Sciences Group, Inc. (HESG) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate Health Sciences Group, Inc.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2012
P/E Ratio
-0.01
Cash-Rich Deficit
P/B Ratio
0.00
Strong
WeakModerateStrong
Earnings Yield
-145.61%
Yield Gap

Profitability Health

2012
Return on Equity
-9.14%
Weak
WeakModerateStrong
Operating Margin
-15.20%
Weak
WeakModerateStrong
Net Profit Margin
-15.20%
Weak
WeakModerateStrong

Growth Indicators

2012
Revenue Growth
-
No data
Net Income Growth
-
No data
EPS Growth
-
No data

Efficiency & Liquidity

2012
Current Ratio
0.31
Weak
WeakModerateStrong
Quick Ratio
0.18
Weak
WeakModerateStrong
Asset Turnover
0.35x
Weak
WeakModerateStrong
Inventory Turnover
6.14x
Strong
WeakModerateStrong

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2012
Free Cash Flow Yield
112.22%
Strong
WeakModerateStrong
EV / Free Cash Flow
7.60x
Strong
WeakModerateStrong
Net Debt / EBITDA
-7.12x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.000
Strong
WeakModerateStrong
Return on Invested Capital
-5.95%
Weak
WeakModerateStrong
Cash Conversion Cycle
92.10 days
Weak
WeakModerateStrong

Fortress screener guardrails

2/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for HESG.

View Financial Statements